Torsten Hoffmann
Impact in
- Microbiology top 1%
- Antimicrobial Peptides and Activities
- Molecular Biology top 2%
- Chemical Synthesis and Analysis
Papers in
-
- Neuropeptides and Animal Physiology 31
- Oncology 35
- Peptidase Inhibition and Analysis 31
- Co-authors
- Keld Fosgerau (1 shared paper)Hans‐Ulrich Demuth (21 shared papers)Ulrich F. Heiser (19 shared papers)Stephan Schilling (13 shared papers)Marcus Gastreich (1 shared paper)Richard Alan Lerner (3 shared papers)Guofu Zhong (3 shared papers)Carlos F. Barbas (3 shared papers)
- Journals
- Biological Chemistry (6 papers)Powder Technology (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Torsten Hoffmann
108 papers receiving 6.5k citations
Torsten Hoffmann's Hit Papers
Peers
Comparison fields: 5 of 159
- Microbiology 492
- Molecular Biology 3.7k
- Oncology 1.3k
- Cellular and Molecular Neuroscience 949
- Biochemistry 304
Countries citing papers authored by Torsten Hoffmann
This map shows the geographic impact of Torsten Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Hoffmann more than expected).
Fields of papers citing papers by Torsten Hoffmann
This network shows the impact of papers produced by Torsten Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Hoffmann. The network helps show where Torsten Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Torsten Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peptide therapeutics: current status and future directions Hit paper breakdown → | 2014 | 2542 |
| 2 | 1997 | 352 | |
| 3 | 2008 | 313 | |
| 4 | 2003 | 273 | |
| 5 | 1998 | 201 | |
| 6 | 2019 | 176 | |
| 7 | 2004 | 154 | |
| 8 | 1997 | 142 | |
| 9 | 2000 | 104 | |
| 10 | 2008 | 99 | |
| 11 | 2002 | 98 | |
| 12 | 2011 | 83 | |
| 13 | 2003 | 83 | |
| 14 | 2007 | 82 | |
| 15 | 2006 | 73 | |
| 16 | 2008 | 70 | |
| 17 | 2020 | 68 | |
| 18 | 2001 | 63 | |
| 19 | 2017 | 62 | |
| 20 | 2013 | 61 |
About Torsten Hoffmann
Torsten Hoffmann is a scholar working on Cellular and Molecular Neuroscience, Oncology, Molecular Biology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 113 papers that have together received 6.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (31 papers), Neuropeptides and Animal Physiology (31 papers), Diabetes Treatment and Management (13 papers), Alzheimer's disease research and treatments (10 papers), Glycosylation and Glycoproteins Research (10 papers), Amino Acid Enzymes and Metabolism (10 papers), Granular flow and fluidized beds (9 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Microbiology (492 citations), Molecular Biology (3.7k citations), Oncology (1.3k citations), Cellular and Molecular Neuroscience (949 citations) and Biochemistry (304 citations). Torsten Hoffmann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Keld Fosgerau, Hans‐Ulrich Demuth, Ulrich F. Heiser, Stephan Schilling, Marcus Gastreich, Richard Alan Lerner, Guofu Zhong, Carlos F. Barbas, Hans‐Ulrich Demuth and Susanne Manhart. Their work appears in journals such as Biological Chemistry, Powder Technology, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.